NSE - Delayed Quote INR

Glenmark Pharmaceuticals Limited (GLENMARK.NS)

1,589.00
+4.20
+(0.27%)
At close: June 6 at 3:30:01 PM GMT+5:30

Research Analysis

Earnings Per Share

Consensus EPS
 

Revenue vs. Earnings

Revenue 32.56B
Earnings 2.1B

Q2'24

Q3'24

Q4'24

Q1'25

0
10B
20B
30B
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Analyst Price Targets

1,300.00 Low
1,678.42 Average
1,589.00 Current
2,011.00 High

Earnings Estimate

Currency in USD Current Qtr. (Jun 2025)Next Qtr. (Jan 1970)Current Year (2026)Next Year (2027)
No. of Analysts ----109
Avg. Estimate 0061.0474.75
Low Estimate 0058.371.9
High Estimate 0064.380.1
Year Ago EPS 12.06--4761.04

Revenue Estimate

Currency in USD Current Qtr. (Jun 2025)Next Qtr. (Jan 1970)Current Year (2026)Next Year (2027)
No. of Analysts ----88
Avg. Estimate ----147.58B165.2B
Low Estimate ----145.53B161.61B
High Estimate ----149.14B169.72B
Year Ago Sales ----133.22B147.58B
Sales Growth (year/est) ----10.78%11.94%

Earnings History

Currency in INR 6/30/2024 9/30/2024 12/31/2024 3/31/2025
EPS Est. 11.314.714.0512.1
EPS Actual 12.0612.5520.737.21
Difference 0.76-2.156.68-4.89
Surprise % 6.73%-14.63%47.54%-40.39%

EPS Trend

Currency in USD Current Qtr. (Jun 2025)Next Qtr. (Jan 1970)Current Year (2026)Next Year (2027)
Current Estimate 0061.0474.75
7 Days Ago 0062.1275.64
30 Days Ago 0062.1475.5
60 Days Ago 0062.476.58
90 Days Ago 0062.2676.17

EPS Revisions

Currency in USD Current Qtr. (Jun 2025)Next Qtr. (Jan 1970)Current Year (2026)Next Year (2027)
Up Last 7 Days ----33
Up Last 30 Days ----34
Down Last 7 Days ----44
Down Last 30 Days ----54

Growth Estimates

Current Qtr.Next Qtr.Current YearNext Year
GLENMARK.NS ----29.87%22.48%
S&P 500 13.13%2.46%7.55%14.08%

Related Tickers